[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept

SIMPLE SUMMARY: The radiological response assessment of neuroendocrine tumors (NET) to peptide receptor radionuclide therapy (PRRT) using [(177)Lu]DOTATOC is still suboptimal due to the high variability in targeted somatostatin receptor 2 (SSTR-2) expression and histological heterogeneity among pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Laudicella, Riccardo, Comelli, Albert, Liberini, Virginia, Vento, Antonio, Stefano, Alessandro, Spataro, Alessandro, Crocè, Ludovica, Baldari, Sara, Bambaci, Michelangelo, Deandreis, Desiree, Arico’, Demetrio, Ippolito, Massimo, Gaeta, Michele, Alongi, Pierpaolo, Minutoli, Fabio, Burger, Irene A., Baldari, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870649/
https://www.ncbi.nlm.nih.gov/pubmed/35205733
http://dx.doi.org/10.3390/cancers14040984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870649/
https://www.ncbi.nlm.nih.gov/pubmed/35205733
http://dx.doi.org/10.3390/cancers14040984

Ejemplares similares